4-(Methylamino)benzoic acid (10541-83-0)
Specifications
CAS:
10541-83-0
End Use:
Methotrexate
M.F.:
C8H9NO2
M.W.:
151.16
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:
Methotrexate CAS: 10541-83-0
,98% Methotrexate
,10541-83-0 Methotrexate
Introduction
4-(Methylamino)benzoic acid is used as intermediate of Methotrexate.
Product Name: | 4-(Methylamino)benzoic acid |
CAS No.: | 10541-83-0 |
Assay: | 98% |
End Use: | Methotrexate |
Molecular Formula: | C8H9NO2 |
Molecular Weight: | 151.16 |
Shelf Life: | 2 Years |
Package: | 25kg/drum |
Related Products
Methotrexate Disodium Salt (7413-34-5)
CAS: 7413-34-5; anti-tumor ; arthritis; rheumatoid
6-(chloromethyl)pteridine-2,4-diamine monohydrochloride (82778-08-3)
CAS: 82778-08-3; anti-tumor ; arthritis; rheumatoid
2,4-diamino-6-(hydroxymethyl)-pteridine (945-24-4)
CAS: 945-24-4; anti-tumor ; arthritis; rheumatoid
2,4-diamino-6-(hydroxymethyl)-pteridine hydrochloride (73978-41-3)
CAS: 73978-41-3; anti-tumor ; arthritis; rheumatoid
1,1,3-Tribromoacetone (3475-39-6)
CAS: 3475-39-6; anti-tumor ; arthritis; rheumatoid
Pyrimidinetetramine sulfate (5392-28-9)
CAS: 5392-28-9; anti-tumor ; arthritis; rheumatoid
Methotrexate (59-05-2)
CAS: 59-05-2; anti-tumor ; arthritis; rheumatoid
Image | Part # | Description | |
---|---|---|---|
Methotrexate Disodium Salt (7413-34-5) |
CAS: 7413-34-5; anti-tumor ; arthritis; rheumatoid
|
||
6-(chloromethyl)pteridine-2,4-diamine monohydrochloride (82778-08-3) |
CAS: 82778-08-3; anti-tumor ; arthritis; rheumatoid
|
||
2,4-diamino-6-(hydroxymethyl)-pteridine (945-24-4) |
CAS: 945-24-4; anti-tumor ; arthritis; rheumatoid
|
||
2,4-diamino-6-(hydroxymethyl)-pteridine hydrochloride (73978-41-3) |
CAS: 73978-41-3; anti-tumor ; arthritis; rheumatoid
|
||
1,1,3-Tribromoacetone (3475-39-6) |
CAS: 3475-39-6; anti-tumor ; arthritis; rheumatoid
|
||
Pyrimidinetetramine sulfate (5392-28-9) |
CAS: 5392-28-9; anti-tumor ; arthritis; rheumatoid
|
||
Methotrexate (59-05-2) |
CAS: 59-05-2; anti-tumor ; arthritis; rheumatoid
|
Send RFQ
Stock:
In Stock
MOQ: